Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Status:
Withdrawn
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the abuse liability and examine the reinforcing
effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy,
non-drug dependent volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone